mitoxantrone has been researched along with Cardiac Remodeling, Ventricular in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandão, SR | 1 |
| Reis-Mendes, A | 1 |
| Duarte-Araújo, M | 1 |
| Neuparth, MJ | 1 |
| Rocha, H | 1 |
| Carvalho, F | 1 |
| Ferreira, R | 1 |
| Costa, VM | 1 |
1 other study available for mitoxantrone and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice.
Topics: Amino Acids; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Doxorubicin; Male; Mice; Mitoxant | 2023 |